Strs Ohio acquired a new position in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 194,100 shares of the company's stock, valued at approximately $452,000. Strs Ohio owned approximately 0.45% of Quipt Home Medical at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Jane Street Group LLC bought a new stake in shares of Quipt Home Medical in the 1st quarter valued at about $124,000. Pale Fire Capital SE bought a new stake in shares of Quipt Home Medical in the 1st quarter valued at about $574,000. Russell Investments Group Ltd. lifted its stake in shares of Quipt Home Medical by 6.5% in the 1st quarter. Russell Investments Group Ltd. now owns 969,822 shares of the company's stock valued at $2,260,000 after acquiring an additional 59,204 shares during the last quarter. Nuveen LLC bought a new stake in shares of Quipt Home Medical in the 1st quarter valued at about $350,000. Finally, Kanen Wealth Management LLC lifted its stake in shares of Quipt Home Medical by 108.4% in the 1st quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock valued at $6,919,000 after acquiring an additional 1,544,529 shares during the last quarter. 42.85% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have commented on the company. Canaccord Genuity Group upped their price target on Quipt Home Medical from $1.70 to $2.30 and gave the company a "hold" rating in a research report on Tuesday, August 19th. Wall Street Zen raised Quipt Home Medical from a "sell" rating to a "hold" rating in a research report on Saturday, August 16th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $3.15.
Read Our Latest Research Report on QIPT
Quipt Home Medical Stock Performance
Quipt Home Medical stock opened at $2.72 on Tuesday. The company has a quick ratio of 0.75, a current ratio of 1.15 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $118.16 million, a P/E ratio of -11.33 and a beta of 0.60. The stock's 50 day moving average is $2.36 and its 200 day moving average is $2.14. Quipt Home Medical Corp. has a twelve month low of $1.35 and a twelve month high of $3.27.
Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last posted its quarterly earnings results on Monday, August 11th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.10). Quipt Home Medical had a negative return on equity of 9.78% and a negative net margin of 4.30%.The company had revenue of $58.30 million during the quarter, compared to analysts' expectations of $80.37 million. On average, equities research analysts predict that Quipt Home Medical Corp. will post -0.05 earnings per share for the current fiscal year.
Quipt Home Medical Company Profile
(
Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.